Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20883704)

  • 21. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
    Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
    Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-10 in development and cancer.
    Lund AH
    Cell Death Differ; 2010 Feb; 17(2):209-14. PubMed ID: 19461655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
    Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
    Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
    Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
    Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
    Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
    Chen F; Hu SJ
    J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.
    Xu RS; Wu XD; Zhang SQ; Li CF; Yang L; Li DD; Zhang BG; Zhang Y; Jin JP; Zhang B
    Int J Oncol; 2013 Feb; 42(2):676-82. PubMed ID: 23258531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis.
    Wang YX; Zhang XY; Zhang BF; Yang CQ; Chen XM; Gao HJ
    J Dig Dis; 2010 Feb; 11(1):50-4. PubMed ID: 20132431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential expression of colon cancer microRNA in microarry study].
    Ma Q; Yang L; Wang C; Yu YY; Zhou B; Zhou ZG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):344-8. PubMed ID: 21826996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).
    Wong MY; Yu Y; Walsh WR; Yang JL
    Int J Oncol; 2011 May; 38(5):1189-95. PubMed ID: 21399872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
    Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC
    PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH.
    Kim HR; Roe JS; Lee JE; Hwang IY; Cho EJ; Youn HD
    Biochem Biophys Res Commun; 2012 Feb; 418(4):682-8. PubMed ID: 22301190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells.
    Li Y; Gong P; Hou JX; Huang W; Ma XP; Wang YL; Li J; Cui XB; Li N
    J Immunol Res; 2018; 2018():7498514. PubMed ID: 30175154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.
    Herbert KJ; Cook AL; Snow ET
    J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-143 and -145 in colon cancer.
    Akao Y; Nakagawa Y; Naoe T
    DNA Cell Biol; 2007 May; 26(5):311-20. PubMed ID: 17504027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.